Description
Cagrilintide + Semaglutide is a combination of two synthetic peptide research compounds studied for their complementary activity on amylin and GLP-1 receptors. This combination is commonly used in controlled laboratory research to investigate metabolic regulation, appetite signalling, glucose homeostasis, and endocrine pathways. It is of interest for studies exploring synergistic peptide interactions and energy balance mechanisms. This combination is supplied strictly for research purposes only and is not intended for human or veterinary use.
Reviews
There are no reviews yet.